OLIG1 and adenocarcinoma: We found that that 36% (n = 9) of the adenocarcinomas and 59% (n = 20) of the SCCs showed loss of OLIG1 DNA compared to tumor-free lung, and the frequency of deletion was significantly higher in SCCs (p = 0.042, one-tail Z-test) (Figure 2D).